ADCs therapy doubles the survival of patients with the “most aggressive breast cancer”

How to evaluate whether ADCs therapy is suitable for you

For breast cancer patients, whether to choose ADCs therapy depends on many factors. Here are a few key steps to evaluate whether this therapy is suitable for you:

1. Determine the cancer subtype: Different subtypes of breast cancer, such as HER2-positive and triple-negative, respond differently to ADCs therapy. Understanding the type of cancer is the first step.
2. Determine the cancer stage: ADCs therapy is mainly used for patients with advanced breast cancer. Patients in the early stage can consider traditional treatments such as surgery or radiotherapy and chemotherapy.
3. Evaluate previous treatment plans: For patients who have received chemotherapy but have not responded well, ADCs therapy may be an effective follow-up option.
4. Consult an oncologist: Discuss your specific situation with a professional doctor, including past treatment experience, health status and personal preferences, and comprehensively consider the risks and benefits of treatment.

Limitations of ADCs

The application of ADC therapy in the treatment of breast cancer has achieved remarkable results, especially in the field of HER2-positive and triple-negative breast cancer, providing new treatment options. With the development of more clinical trials, ADCs therapy is expected to become the preferred treatment option for more breast cancer patients in the future.

Nevertheless, the heterogeneity of triple-negative breast cancer remains a challenge, and some patients may develop resistance to ADCs therapy. More research is needed in the future to address these issues.